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Efficacy of Helicobacter pylori (H. pylori) eradication therapy has declined due to rapid
rises in antibiotic resistance. We investigated how increased temperature affected
H. pylori (NCTC 11637) growth and its sensitivity to metronidazole in vitro. We performed
transcriptomic profiling using RNA-sequencing to identify differentially expressed genes
(DEGs) associated with increased temperature. Transcriptional pathways involved
in temperature-driven metronidazole resistance changes were analyzed through
bioinformatic and literature curation approaches. We showed that H. pylori growth
was inhibited at 41◦C and inhibition was more apparent with prolonged incubation.
Resistance to metronidazole was also reduced—minimum inhibitory concentration
for metronidazole decreased from > 256 µg/ml at 37◦C to 8 µg/ml at 41◦C after
culturing for 3 days. RNA-sequencing results, which were highly concordant within
treatment conditions, revealed more than one third of genes (583/1,552) to be
differentially expressed at increased temperatures with similar proportions up and down-
regulated. Quantitative real-time PCR validation for 8 out of 10 DEGs tested gave
consistent direction in gene expression changes. We found enrichment for redox and
oxygen radical pathways, highlighting a mechanistic pathway driving temperature-
related metronidazole resistance. Independent literature review of published genes
associated with metronidazole resistance revealed 46 gene candidates, 21 of which
showed differential expression and 7 out of 9 DEGs associated with “redox” resistance
pathways. Sanger sequencing did not detect any changes in genetic sequences for
known resistance genes rdxA, frxA nor fdxB. Our findings suggest that temperature
increase can inhibit the growth and reduce H. pylori resistance to metronidazole. Redox
pathways are possible potential drivers in metronidazole resistance change induced
by temperature. Our study provides insight into potential novel approaches in treating
antibiotic resistant H. pylori.
Keywords: Helicobacter pylori, temperature, transcriptomics, antibiotic resistance, metronidazole
Abbreviations: BP, biological process; CC, cellular component; CFU, colony forming units; DEGs, differentially expressed
genes; E-test, Epsilometer test; GC, gastric cancer; GO, Gene Ontology; H. pylori, Helicobacter pylori; KEGG, Kyoto
Encyclopedia of Genes and Genomes; MF, molecular function; MIC, minimum inhibitory concentration; PBS, phosphate-
buffered saline; PCR, polymerase chain reaction; Pfam, protein families database.
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INTRODUCTION
Helicobacter pylori (H. pylori) infection has been established as
the main cause of various gastroduodenal diseases including
chronic gastric inflammation, peptic ulcer disease and gastric
cancer (GC) and it is classified as a class I carcinogen (Ishaq
and Nunn, 2015). H. pylori resides in human gastric mucosa
and affects nearly half of the human population worldwide with
prevalence exceeding 80% in certain regions such as parts of Asia
(Hooi et al., 2017). Eradication of H. pylori has been shown to
reduce GC incidence across a range of risk groups (Takenaka
et al., 2007; Kosunen et al., 2011).
The standard triple therapy, consisting of a proton pump
inhibitor combined with clarithromycin and amoxicillin or
metronidazole, has been the mainstay of treatment for H. pylori
infection over the last two decades. However, rising antibiotic
resistance has made standard triple therapy less effective—
bismuth and non-bismuth based quadruple therapies have
also been introduced depending on efficacy and resistance
patterns locally (Graham and Fischbach, 2010). Resistance to
clarithromycin and metronidazole also varies between regions
across the world and have hampered the elimination of H. pylori
(Kim et al., 2015). In China, the resistance rate for clarithromycin
is around 50% whilst resistance to metronidazole ranges from
41.6 to 95.4% in Southeast China (Su et al., 2013; Thung
et al., 2016). Various mechanisms have been shown to affect
H. pylori antibiotic resistance under physiological conditions
(Hu et al., 2016; Alba et al., 2017). Point mutations in 23S
rRNA and changes in efflux pump systems have been shown
to confer resistance to macrolides such as clarithromycin
(Francesco et al., 2011). In addition, reduced activities in nitro-
reductase (rdxA), flavinoxido reductase (frxA) and ferrodoxin-
like enzymes (frxB) lead to reduced activation of metronidazole
(Francesco et al., 2011).
Changes in environmental conditions lead to alterations in
transcriptomic profiles of H. pylori (Thompson et al., 2003; De
la Cruz et al., 2017). Previous evidence has demonstrated local
nanoparticle heating inhibits H. pylori growth and virulence as
a potential alternate approach to treating H. pylori infections
(Wu et al., 2019; Zhi et al., 2019). Whilst temperature differences
have led to changes leading to increased antibiotic resistance in
other bacteria species (Liang et al., 2016; Loughman et al., 2016;
De Silva et al., 2018), the effects of temperature on antibiotic
resistance and transcriptomic changes in H. pylori have not been
investigated previously.
In this study, we examine the effect of changes in temperature
on the growth of H. pylori and its sensitivity to metronidazole
using a reference resistant strain. In addition, we investigate
perturbations in transcriptomic profiles underlying changes in
temperature-driven antibiotic susceptibility.
MATERIALS AND METHODS
Bacterial Strain and Culture Conditions
H. pylori type strain NCTC 11637 (Lock et al., 2001) was
used for this study and 16S rRNA identification was used
to verify the strains. Bacteria was cultured on Karmali Agar
Base (CM0935, Oxoid, United Kingdom) supplemented with
5% sterile defibrinated sheep blood (Beijing XLF Medical Sales
Co. Ltd, China) for 3–5 days at 37◦C, under microaerophilic
conditions: microaerobic gas mixture composed of 5% oxygen,
10% carbon dioxide, and 85% nitrogen (GEN bag microaer,
BioMérieux, France). H. pylori were subcultured three times
before each experiment.
Comparison of H. pylori Growth at
Different Temperatures
H. pylori NCTC 11637 was cultured at 37 and 41◦C to evaluate
the effects of elevated temperature on bacteria growth. Bacteria
was resuspended in phosphate-buffered saline (PBS) to 8 different
dilutional concentrations (0.5, 0.25, 0.125, 0.0625, 0.03125, 0.015,
0.0075, 0.003 McFarland). 90 mm plates seeded with 0.1 ml
of bacterial suspensions were incubated at 37◦C as controls.
In the treatment group, 0.1 ml bacterial suspensions at the 8
dilution concentrations were seeded on 3 sets of 8 plates. After
inoculation, the 3 sets of plates (each set consists of 8 plates of
different bacterial concentrations) were incubated at 41◦C for
1, 3, and 5 days, respectively, and then incubated at 37◦C for
a further 3 days. Colonies in each plate were counted after the
last incubation.
Antibiotics Susceptibility Testing
In vitro minimum inhibitory concentrations (MICs) of four
antibiotics (amoxicillin, clarithromycin, metronidazole,
tetracycline) against H. pylori NCTC 11637 were tested.
All experiments were performed in triplicate. The MICs of
amoxicillin, metronidazole and tetracycline against H. pylori
were determined via the Epsilometer test (E-test) using an E-strip
(BioMerieux SA, France) and the Kirby-Bauer method was
used for clarithromycin sensitivity. H. pylori NCTC 11637 was
cultured as described above, and the third-generation colonies
were selected and suspended in PBS to the turbidity of a 2
McFarland standard. Then, 0.1 ml of the bacterial suspension
was evenly coated on Karmali Agar Base. Each agar plate
was left to dry for 15 min before E-strip was affixed and the
plates were incubated as described above. MICs were defined
as the lowest concentration that allowed no visible growth
after 72 h of incubation at 37◦C. The clinical breakpoints for
amoxicillin, clarithromycin, metronidazole, and tetracycline are
defined as: >0.125, >0.5, >8, and >1 mg/L, respectively, as per
European Committee on Antimicrobial Susceptibility Testing
Breakpoints version 8 (European Committee on Antimicrobial
Susceptibility Testing [ECUCAST], 2018).
RNA Extraction and Transcriptomic
Analysis
H. pylori NCTC 11637 strain was divided into two groups
in triplicate. The experimental group was treated at 41◦C for
3 days. The control group was treated at 37◦C for 3 days.
The cells were harvested, and total RNA was extracted and
purified using the Bacterial RNA kit (Omega Bio-tek, GA,
United States) according to manufacturer protocols. Quality
Frontiers in Microbiology | www.frontiersin.org 2 May 2021 | Volume 12 | Article 681911
fmicb-12-681911 May 16, 2021 Time: 16:11 # 3
Gong et al. Heat Alters Metronidazole Resistance
control of each RNA sample was performed with Agilent 2100
Bioanalyzer (Agilent Technologies, Beijing, China). The cDNA
libraries were constructed using NEBNext R© UltraTM RNA Library
Prep Kit (New England Biolabs, Ipswich, MA, United States)
and submitted for sequencing using IlluminaHiseq 4000. Library
construction and sequencing were performed by Allwegene
BioTech Co., Ltd. (Beijing, China). Raw reads were filtered
using Trimmomatic v0.33 (Bolger et al., 2014) and mapped
to the H. pylori NCTC 11637 genome (National Center for
Biotechnology Information [NCBI], 2012) using Bowtie2 v2.2.6
(Langmead and Salzberg, 2012) with default parameters. Genes
were quantified using HTSeq v0.6.0 (Anders et al., 2015).
Differentially expressed genes (DEGs) were analyzed by DESeq2
v1.22.1 in R (Love et al., 2014). Genes with absolute log2 fold-
changes > 1 and multiple testing adjusted (Benjamini–Hochberg
procedure) q < 0.05 were considered as DEGs.
Gene Expression Using qRT-PCR
Quantitative real-time polymerase chain reaction (qRT-PCR)
assays were performed using the same samples analyzed (3
controls at 37◦C and 3 at 41◦C for 3 days) as in the
RNA-seq transcriptomic analyses. 10 genes with differential
expression levels identified using RNA sequencing were selected
for subsequent validation (5 of the most significantly associated
genes and 5 associated with metronidazole resistance from
bioinformatic screening as described in Curation of resistance
related genes). Gene-specific primers (Supplementary Table 1A)
were designed and purchased from Invitrogen (Beijing, China).
Three technical replicates were performed for each biological
sample. First strand cDNA was synthesized using PrimeScriptTM
RT reagent Kit with gDNA Eraser (Takara, Japan) according to
manufacturer instructions. qRT-PCR reactions were performed
using an ABI Prism 7500 Sequence Detection System (Perkin-
Elmer Applied Biosystems, Foster City, CA). H. pylori 16S rRNA
was used as housekeeping internal control. Gene expression and
log2 fold-changes were analyzed using the 2−11CT algorithm
(Livak and Schmittgen, 2001). After quality control, one
biological sample at 37◦C exhibited low readouts across all genes
compared to the other 2 biological samples (which did not show
low readouts in RNA-seq) and was excluded from analysis.
GO and KEGG Pathway Analysis
We mapped the genes to Entrez Gene symbols first. Gene
Ontology (GO) enrichment analysis comprising cellular
component (CC), molecular function (MF), and biological
process (BP) were conducted for DEGs in R with GOSeq v1.26.0
and topGO v2.26.0 package, using the H. pylori 11637 reference
strain annotated by Pfam (protein families database) (El-Gebali
et al., 2019) as background. KOBAS v3.0 (Xie et al., 2011) was
used to perform Kyoto Encyclopedia of Genes and Genomes
(KEGG) pathway enrichment analysis for DEGs using H. pylori
26695 reference strain as background. The p < 0.05 adjusted
for multiple testing (q-value) using the Benjamini-Hochberg
method was used as significance thresholds for GO and KEGG
pathway enrichment analyses. We also performed sensitivity
analyses using absolute log2 fold-change > 1.5, q < 0.05 as
cut-offs for DEGs.
Curation of Resistance Related Genes
Curation of All Mapped Genes Into Metronidazole
Resistance Pathways
Metronidazole antibiotic resistance pathways in H. pylori based
on four groups of broad mechanisms: (1) reduced activity of
nitro-reductases, (2) increased activity of the oxygen radical
scavenger system, (3) reduced uptake and increased efflux,
and (4) increased activity of the DNA repair enzymes, were
determined from current literature (Hu et al., 2016; Alba et al.,
2017). All mapped genes (n = 1,552) were manually curated by
two independent reviewers to determine whether each is related
to one of the four mechanisms based on gene function and gene
description. Genes with assignments which agree between the
two reviewers were included.
Curation of Genes Associated With Metronidazole
Resistance in Literature
Queries were made in PubMed using keywords “helicobacter
pylori,” “metronidazole,” and “resist∗” and subsequently manually
curated to create a list of reported H. pylori metronidazole
resistance genes. DEGs identified in this study were then mapped
to the list of literature reported genes. Enrichment tests were
performed by permutation testing (10,000 times).
Detection and Sequencing of rdxA, frxA,
and fdxB
For both 37◦C and 41◦C conditions, conventional polymerase
chain reaction (PCR) amplification was performed. Specific
reagents, primers and conditions are detailed in Supplementary
Table 1B. PCR, gel electrophoresis and DNA sequencing via
Sanger sequencing method were performed following standard
manufacturer protocols.
RESULTS
Increased Temperature Inhibits H. pylori
Growth
The effect of elevated temperature on H. pylori (NCTC 11637
strain) growth was evaluated at 37◦C (control group) and at
41◦C for 1, 3, and 5 days. Growth of H. pylori was significantly
inhibited after incubation at 41◦C with inhibition more apparent
with prolonged incubation (Figure 1A). At an inoculation
concentration of 0.002 McFarland, bacterial colony count of the
control group was 4,288 ± 184 CFU/ml. The counts decreased
to 2,970 ± 462, 2,255 ± 575, and 1,990 ± 187 CFU/ml after 1,
3, and 5 days of treatment under 41◦C, respectively (p = 0.026
[1 day], p = 0.018 [3 days], p = 0.00011 [5 days], compared
with control group).
Temperature Change Increases
Sensitivity of H. pylori to Metronidazole
We investigated the effect of increased temperature on
sensitivities of the metronidazole-resistant H. pylori NCTC
11637 strain to metronidazole using the E-test strip. The
minimum inhibitory concentration (MIC) for metronidazole
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FIGURE 1 | (A) Growth inhibition of H. pylori at different temperature conditions. (B) Changes in metronidazole susceptibility at different temperature conditions.
under the 37◦C culture condition (control group) was > 256
µg/ml. After culturing at 41◦C for 3 days, MIC of H. pylori to
metronidazole decreased to 8 µg/ml (Figure 1B), which is the
breakpoint of metronidazole resistance. The NCTC 11637 strain
was sensitive to clarithromycin, amoxicillin and tetracycline
and this did not change under increased culture temperature
conditions (Supplementary Table 2). There was no growth in
the H. pylori subculture inoculation after returning from 41
to 37◦C.
Transcriptome Analyses Identify
Changes in Drug Resistance Genes
Identification of Differentially Expressed Genes by
RNA-Sequencing
To study the transcriptomic changes which may drive decreased
resistance to increased temperature, we used RNA sequencing
to assess changes in gene expression between 37 and 41◦C.
Illumina paired-end sequencing of 6 samples (3 cultured at
37◦C and 3 at 41◦C) yielded a total of 252,222,378 clean reads.
70.9–80.1% reads of samples were mapped to the annotated
H. pylori NCTC 11637 genome culminating in 1,552 mapped
genes. Gene expression measurements were highly consistent
between biological replicates within each temperature condition
(Pearson’s r: 0.97–0.99 within condition, Figure 2A). 583 out of
1,552 mapped genes were significantly differentially expressed
at absolute log2 fold-change > 1 and q < 0.05 after incubation
at 41◦C for 3 days compared to 37◦C, of which 292 were
up-regulated and 291 were down-regulated (Figures 2B,C and
Supplementary Table 3).
Gene Expression Measurements Using qRT-PCR
We selected 10 DEGs, 5 most significantly associated genes
and 5 related to metronidazole resistance (Materials and
Methods) for measurement using qRT-PCR. 8 out of the 10
DEGs showed consistent direction in log fold gene expression
changes (Figure 3). All 5 of DEGs with the strongest
statistical significance of association [HP17_RS13720 (HP1076),
HP_RS12585 (HP0115), flgL, HP17_RS17120 (HP0630), and
HP17_RS13130 (HP1286)] showed directionally concordant
changes using qRT-PCR.
GO and KEGG Pathway Enrichment Analysis
To investigate molecular and functional pathway changes
as result of increased temperature, GO and KEGG pathway
enrichment analyses of DEGs were performed. Whilst no
pathways were significantly enriched after adjusting for
multiple testing, we found enrichment at nominal significance
(p < 0.05) for drug, vitamin, superoxide and reactive oxygen
species metabolic GO processes. Cellular component was
enriched for ribosome, non-membrane-bounded organelle
and cytoplasm components at nominal threshold. Molecular
function enrichment included structural constituent of ribosome,
oxidoreductase activity, superoxide dismutase activity and
various symporter activities (Supplementary Tables 4.1,
4.2). Sensitivity analyses, using DEGs defined using more
stringent thresholds of absolute log2 fold-change > 1.5 adjusted
q < 0.05 showed similar results. Both analyses showed GO
enrichment for reactive oxygen species and metabolic processes
(Supplementary Table 5).
DEGs Are Enriched for Specific
Metronidazole Resistance Pathways
All mapped genes were curated base on gene description and
function into four broad metronidazole resistance pathways: (1)
nitro-reductases, (2) oxygen radical scavenger, (3) drug uptake
and efflux and (4) DNA repair related. 126 genes were related to
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FIGURE 2 | Differentially expressed genes (DEGs) by RNA-seq. (A) Pearson’s correlation heatmap of expression of all mapped genes (B) Hierarchical clustered heat
map of significantly differentially expressed genes (583). (C) Volcano plot displaying DEGs. The vertical axis corresponds to the q-value, the horizontal axis displays
the log2 fold-change. The red dots represent the up-regulated expressed transcripts (292), the green dots represent the down-regulated transcripts (291). Vertical
and horizontal dashed lines indicate absolute log2 fold-change = 1 and adjusted p = 0.05, respectively.
one of the four pathways (Supplementary Table 6 and Table 1).
Nitro-reductase related pathways were enriched for DEGs under
increased temperature condition at 41◦C (permutation 10,000
times, empirical p= 0.0038). Oxygen radical scavenger pathways
were borderline significant for enrichment of DEGs (empirical
p= 0.05).
In addition, we performed independent literature search
for published genes associated with metronidazole resistance.
Our literature search revealed 46 gene candidates related to
metronidazole resistance in H. pylori which were classified into
10 categories (Supplementary Table 7). These genes were all
found within the 1,552 genes sequenced in our study. 21 of
the 46 genes showed differential expression. Permutation testing
did not reveal significant enrichment amongst resistance genes
overall for DEGs (empirical p= 0.15). However, genes associated
with “redox” resistance pathways were significantly enriched for
FIGURE 3 | Barplot showing log2 fold-changes at incubation of 41◦C for 3
days compared to 37◦C using RNA-Seq and qRT-PCR methods for 10
selected DEGs. Error bars indicate standard deviations from the mean. Genes
ordered by RNA-Seq log2 fold-changes.
DEGs with 7 out of 9 genes differentially expressed (empirical
p = 0.016). Other pathways with more than 5 genes in each
category did not show enrichment for DEGs.
Metronidazole is a prodrug which is first activated by
nitro-reductase (mutated in resistant H. pylori NCTC 11637
strains; Debets-Ossenkopp et al., 1999) to produce oxygen
radicals toxic to bacteria through DNA damage (Cederbrant
et al., 1992; van der Wouden et al., 2001). We found
that expression of NAD(P)H-dependent oxidoreductase (rdxA
[HP17_RS12480]) was downregulated (log2 fold-change: −1.51,
p = 3.8 × 10−5). In addition, we also found that superoxidase
dismutase (Sod [HP17_RS11110]) expression, an important
protein in detoxifying free oxygen radicals, was downregulated
(log2 fold-change: −3.29, p = 4.1 × 10−45) and expression
of its transcriptional repressor, ferric uptake regulator (Fur
[HP17_RS13980]) (Tsugawa et al., 2011), was upregulated (log2
fold-change: 2.14, p= 1.7× 10−8).
Key Resistance Gene Sequences Not
Altered by Increased Temperature
We independently tested established H. pylori resistance genes
rdxA, frxA, and fdxB through Sanger sequencing to see if
increased temperature conditions led to structural changes
in these genes. All three genes were successfully detected
and amplified though PCR in both temperature conditions
(Supplementary Figure 1). Sanger sequencing did not detect
any changes in genetic sequences for rdxA, frxA nor fdxB
(Supplementary Figures 2–4).
DISCUSSION
Our study showed that increased temperature inhibited the
growth of metronidazole resistant H. pylori strain (NCTC
11637) consistent with previous reported changes in growth
of sensitive H. pylori strains (26695 strain) under elevated
temperatures (Jiang and Doyle, 1998). In addition, we present
the novel finding that elevated temperature (41◦C) increased
sensitivities of the resistant strain to metronidazole which
has not been reported previously. Studies have identified
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TABLE 1 | Curation of DEGs into metronidazole resistance pathways (adjusted p < 0.05).




HP17_RS15190 DNA (cytosine-5-)-methyltransferase 2.737 8.89E–31
HP17_RS17710 DNA cytosine methyltransferase 2.476 7.30E–05
HP17_RS14395 DNA polymerase III subunit delta’ 2.209 1.39E–11
HP17_RS13655 DNA translocase FtsK −2.026 6.78E–18
HP17_RS10090 DNA gyrase subunit A −1.928 1.28E–16
HP17_RS10700 DNA-binding response regulator −1.904 5.06E–13
HP17_RS12590 DNA topoisomerase I 1.893 1.46E–16
HP17_RS15830 Thymidylate synthase (FAD) −1.602 2.12E–11
HP17_RS10880 DNA (cytosine-5-)-methyltransferase 1.473 7.16E–10
HP17_RS14590 DNA-directed RNA polymerase subunit beta/beta’ 1.174 2.01E–07
HP17_RS16580 DNA starvation/stationary phase protection protein −1.151 1.86E–07




HP17_RS11900 Glucose/galactose MFS transporter 3.067 7.56E–25
HP17_RS13150 Nicotinamide riboside transporter PnuC 3.043 6.80E–10
HP17_RS11910 Glutamine ABC transporter substrate-binding protein −2.846 3.78E–32
HP17_RS16625 ABC transporter permease 2.690 1.28E–27
HP17_RS13650 MFS transporter −2.222 2.78E–17
HP17_RS15125 Iron chelating transport ATP-binding protein −2.040 1.09E–16
HP17_RS14795 MFS transporter −1.935 2.03E–10
HP17_RS15130 Iron chelating ABC transporter permease −1.932 5.41E–08
HP17_RS16620 ABC transporter ATP-binding protein 1.922 1.14E–07
HP17_RS10180 Lysine transporter −1.874 9.77E–03
HP17_RS16500 SulP family inorganic anion transporter 1.850 1.48E–02
HP17_RS16985 MFS transporter −1.794 1.49E–14
HP17_RS16850 Autotransporter domain-containing protein −1.754 1.86E–12
HP17_RS17445 AI-2E family transporter −1.582 6.10E–06
HP17_RS15475 ABC transporter ATP-binding protein −1.563 1.09E–06
HP17_RS17915 ABC transporter ATP-binding protein 1.527 1.71E–05
HP17_RS16110 ABC transporter substrate-binding protein 1.514 1.10E–06
HP17_RS14930 ABC transporter ATP-binding protein −1.473 9.38E–09
HP17_RS09990 Ferrous iron transport protein B −1.433 2.47E–09
HP17_RS15230 Biopolymer transporter ExbD 1.261 7.33E–08
HP17_RS11620 MATE family efflux transporter 1.222 1.01E–02
HP17_RS13700 ABC transporter ATP-binding protein 1.139 8.19E–07
HP17_RS14700 Molybdenum ABC transporter ATP-binding protein −1.129 1.81E–03
HP17_RS11565 ABC transporter ATP-binding protein 1.068 9.17E–06




HP17_RS17120 Flavodoxin family protein −4.185 1.30E–62
HP17_RS17325 2-oxoglutarate ferredoxin oxidoreductase subunit beta −1.851 3.38E–16
oorC 2-oxoglutarate:acceptor oxidoreductase −1.849 1.07E–15
HP17_RS11960 Flavodoxin −1.664 9.96E–14
HP17_RS15890 Pyruvate ferredoxin oxidoreductase subunit beta −1.651 9.16E–14
HP17_RS17330 2-oxoglutarate synthase subunit alpha −1.632 3.93E–13
HP17_RS12480 NAD(P)H-dependent oxidoreductase −1.512 3.79E–05
porC Pyruvate flavodoxin oxidoreductase subunit gamma −1.345 8.80E–08
HP17_RS15705 Cytochrome c oxidase accessory protein CcoG −1.239 6.23E–08
HP17_RS15895 2-ketoisovalerate ferredoxin oxidoreductase subunit alpha −1.161 1.68E–06
Oxygen-radical scavenging
(3/3 genes, enrichment p = 0.05)
HP17_RS11110 Superoxide dismutase −3.293 4.11E–45
HP17_RS17265 3-methyladenine DNA glycosylase 1.904 1.31E–05
HP17_RS13135 Thiaminase II 1.643 3.72E–04
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thermoregulated antibiotic resistance in some species. Francisella
tularensis showed increased resistance to gentamicin at ambient
temperature (26◦C) compared to mammalian body temperature
(37◦C) (Loughman et al., 2016). Temperature associated
expression changes in antibiotic resistance were observed in
Acinetobacter baumannii ATCC 17978 (De Silva et al., 2018).
This is the first study investigating gene expression changes
with increased temperature in H. pylori. Transcriptomic profiling
showed good internal consistency within treatment conditions
and widespread changes in gene expression with more than
one third of all genes differentially expressed. Previous literature
showed transcriptomic changes in H. pylori with sudden
decreased temperature (Han et al., 2009). Approximately equal
proportion of DEGs was up and down-regulated similar to
findings seen with decreased temperature.
Whilst no specific GO or KEGG pathways were enriched
for DEGs after multiple testing correction, we found nominal
statistical evidence indicating that metabolic processes may
be enriched. Furthermore, permutation analyses based on
annotation of genes for metronidazole resistance mechanisms
and specific metronidazole resistance genes published in
the literature showed enrichment for redox (oxygen radical
scavenger) and nitro-reductase pathways. Metronidazole is a
prodrug which is first activated by nitro-reductase to produce
oxygen radicals toxic to bacteria through DNA damage (van
der Wouden et al., 2001). Increased nitro-reductase activity in
theory leads to reduced metronidazole resistance. We found
reduced expression of nitro-reductases, such as NAD(P)H-
dependent oxidoreductase (rdxA, HP17_RS12480) with heating.
The H. pylori NCTC 11637 strain used in this study contains
a transposon-induced deletion in rdxA which plays a key
role conferring resistance (Debets-Ossenkopp et al., 1999),
thus the NAD(P)H-dependent oxidoreductase produced by the
mutated gene does not provide normal functions regardless of
expression levels.
In addition we also found Sod expression to be downregulated
with elevated temperature. Sod contributes to metronidazole
resistance through mitigating oxygen radical related damage and
increased Sod levels have been associated with development
of metronidazole resistance (Wassmann and Bruchhaus, 2000;
van der Wouden et al., 2001). Interestingly, we observed
an increased expression of a negative transcription regulator
of Sod, Fur, which may also contribute to decreased Sod
expression. Therefore, another plausible mechanism by which
higher temperature leads to reduced metronidazole resistance
may be through decreased Sod expression which leads to
increased susceptibility to superoxide damage. DEGs within
other resistance pathways such as DNA repair, efflux pump
complexes, bacterial flagellar mobility, changes in metabolism or
potential novel pathways may also play a role in temperature
induced reduction in metronidazole resistance. Lastly, we
confirmed that key resistance genes, rdxA, frxA, and fdxB, are
not mutated by increased temperature conditions, suggesting that
resistance changes can be attributed to gene expression or protein
function changes. Further studies would be needed to elucidate
these functional mechanisms in detail. Our approach of studying
transcriptomic changes associated with temperature-related
antibiotic resistance can highlight perturbed gene pathways as
well as suggest candidate genes and pathways as potential novel
drug targets for antimicrobials.
Our study examined the effect of 41◦C temperature on
H. pylori growth, metronidazole resistance and transcriptomic
changes. Further studies are needed to investigate the detailed
mechanisms driving reduced resistance to metronidazole. Effects
at other temperatures as well as using strains with different
profiles and mechanisms of resistance to various other antibiotics
commonly used in H. pylori eradication could also be explored.
Whether in vitro effects of increased temperature are also
reflected in vivo remain to be elucidated.
At present, antibiotics treatment combined with proton-pump
inhibitors is the main approach to treating H. pylori infections.
Unfortunately, efficacy has decreased, due to the rapid rise in
resistance rates (Fallone et al., 2019). Emergence of multi-drug
resistance strains further exacerbates the problem (Boyanova
et al., 2019). H. pylori colonizes and grows in gastric mucosa in
humans which makes local treatment possible. Since the stomach
mucosa of mammal species can withstand temperatures as high
as 46◦C (Kang et al., 2004), raising local temperatures have been
postulated to help eradicate H. pylori in vivo complementing
antibiotic-based therapies. One way to achieve this may be
through well-controlled local photothermal/magnetic thermal
treatments using nanomaterials which have shown early promise
in suppressing bacterial growths (Mocan et al., 2017; Chen
et al., 2018), including H. pylori (Wu et al., 2019). It is recently
reported that gold nanostars@H. pylori-antibodies nanoprobes
could target and kill H. pylori in the stomach in model animals
under near-infrared laser irradiation (Zhi et al., 2019). However,
feasibility and safety of sustained localized thermal treatment
within human gastric mucosa need to be ascertained in a
clinical setting in order for it to become a viable strategy for
H. pylori eradication.
In conclusion, growth of H. pylori and resistance to
metronidazole was significantly inhibited when cultured in vitro
at 41◦C. Transcriptomic analyses showed differential gene
expression changes in more than one third of the genes with
evidence of enrichment pointing to redox pathways as potential
drivers of temperature related reduction in metronidazole
resistance. Expression changes for genes in other resistance
pathways may also play a role in temperature induced
metronidazole sensitivity. Our findings suggest a novel approach
in treating metronidazole and multi-drug resistant H. pylori
in vivo.
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Supplementary Figure 1 | Agarose gel electrophoresis of gene fragments of
H. pylori NCTC 11637 amplified by PCR. (A) Lanes 1–6, PCR fragments of gene
rdxA; (B) Lane 1, PCR fragments of gene frxA of H. pylori NCTC 11637 cultured in
37◦C; Lane 2, PCR fragments of gene frxA of H. pylori NCTC 11637 cultured in
41◦C; Lanes 3–5, PCR fragments of gene fdxB of H. pylori NCTC 11637 cultured
in 37◦C with primer pairs 1–3, respectively, Lanes 6–8, PCR fragments of gene
fdxB of H. pylori NCTC 11637 cultured in 41◦C with primer pairs 1–3, respectively.
Supplementary Figure 2 | The DNA sequence blast of rdxA gene in H. pylori
26695 and H. pylori NCTC 11637. The H. pylori 26695 is sensitive to
metronidazole but H. pylori NCTC 11637 is resistant. Compared with H. pylori
26695, the structural variation of rdxA gene in H. pylori NCTC 11637 included
point mutations and the insertion of mini-IS605, which caused rdxA inactivation
and thus metronidazole resistance. 11637-rdxA-37: the rdxA gene sequence of
H. pylori NCTC 11637 cultured in 37◦C. 11637-rdxA-41: the rdxA gene sequence
of H. pylori NCTC 11637 cultured in 41◦C. 26695-rdxA: the rdxA gene reference
sequence of H. pylori 26695. The dashed rectangle showed the start site of rdxA
gene and the solid rectangle showed the termination site of rdxA gene. The figure
showed that the 11637-rdxA-37 and 11637-rdxA-41 were exactly the same. The
high light region showed the insertion of mini-IS605, one of the endogenous
transposable elements, in H. pylori NCTC 11637.
Supplementary Figure 3 | The DNA sequence blast of frxA gene in H. pylori
26695 and H. pylori NCTC 11637. 11637-frxA-37: the frxA gene sequence of
H. pylori NCTC 11637 cultured in 37◦C. 11637-frxA-41: the frxA gene sequence
of H. pylori NCTC 11637 cultured in 41◦C. 26695-frxA: the frxA gene reference
sequence of H. pylori 26695. The figure showed that the 11637-frxA-37 and
11637-frxA-41 were exactly the same.
Supplementary Figure 4 | The DNA sequence blast of fdxB gene in H. pylori
26695 and H. pylori NCTC 11637. 11637-fdxB-37: the fdxB gene sequence of
H. pylori NCTC 11637 cultured in 37◦C. 11637-fdxB-41: the fdxB gene sequence
of H. pylori NCTC 11637 cultured in 41◦C. 26695-fdxB: the fdxB gene reference
sequence of H. pylori 26695. The figure showed that the 11637-fdxB-37 and
11637-fdxB-41 were exactly the same.
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